FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

FBI arrests leftist Senate hopeful for alleged death threats against Trump, Congress member and daughter

Rideshare passenger held hostage for eight hours during armed standoff with police in swanky neighborhood

Trump Offers New Retirement Account Opportunity to Americans

Bernie Sanders campaigns with controversial Michigan Senate candidate

Building the White House Ballroom Shouldn’t Be a Partisan Issue After Horrific WHCD Shooting

Pritzker calls for criminal investigations into ICE agents over ‘Midway Blitz’ conduct

California leaders mum on $1B high-speed rail detour aimed at preserving disgraced labor leader’s memorial

Research Team Reveals the Secret of Ancient Biblical Manuscript

Tensions between John Thune and Mike Johnson loom over GOP immigration push

After NASCAR’s Greg Biffle And Family Died, Police Think ‘Friends’ Stole from Them

State Department fires back at accusations of ‘empty planes’ rescuing Americans from conflict zones

Inside the coming battle over Virginia’s abortion ballot referendum

Iowa woman died following hernia repair after nurses dismissed painful post-surgery symptoms: lawsuit

Shooting during party at Oklahoma’s Arcadia Lake leaves at least 10 wounded, police say

Marco Rubio spotted behind DJ booth at family wedding as social media reacts to viral clip

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”